3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical focus due to sparse evidence suggesting distinct pharmacological properties. Present studies suggest that 3-HPC may https://www.pinterest.com/pin/1140888518124046392/